Neurologic - GT Medical Technologies

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05342883

Feasibility Study of Resection and GammaTile® Followed by Concomitant External Beam Radiation Therapy (EBRT) and Temozolomide (TMZ) and Adjuvant TMZ in Newly Diagnosed Glioblastoma (GBM).

Device

Gamma Tile

Phase

Phase III

Condition

Newly Diagnosed Glioblastoma (GBM).

Keywords

Newly Diagnosed Glioblastoma (GBM) | Brain tumor